CVS HEALTH Corp Long-Term Concentrated

CIK: 0000064803 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 9, 2024

Total Value ($000): $216,848 (100.0% shares, 0.0% debt)

Holdings (6)

SPY SPDR S P 500 ETF TRUST 72.3%

Value ($000) $156,676 Shares 287,891 Est. Cost $432.89 Unrealized —

VYM VANGUARD WHITEHALL FDS 13.8%

Value ($000) $29,891 Shares 252,032 Est. Cost $111.29 Unrealized —

HDV ISHARES CORE HIGH DIVIDEND ETF 13.7%

Value ($000) $29,687 Shares 273,110 Est. Cost $100.99 Unrealized —

PRU PRUDENTIAL FINANCIAL INC 0.1%

Value ($000) $314 Shares 2,683 Est. Cost $88.87 Unrealized +20.1%

HCAT HEALTH CATALYST INC 0.1%

Value ($000) $206 Shares 32,273 Est. Cost $45.57 Unrealized -85.9%

— LUMIRADX LTD 0.0%

Value ($000) $73 Shares 5,352,106 Est. Cost $8.91 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SPY	SPDR S P 500 ETF TRUST	287,891	$156,676	72.3%	$432.89	—	COM	78462F103
VYM	VANGUARD WHITEHALL FDS	252,032	$29,891	13.8%	$111.29	—	COM	921946406
HDV	ISHARES CORE HIGH DIVIDEND ETF	273,110	$29,687	13.7%	$100.99	—	COM	46429B663
PRU	PRUDENTIAL FINANCIAL INC	2,683	$314	0.1%	$88.87	+20.1%	COM	744320102
HCAT	HEALTH CATALYST INC	32,273	$206	0.1%	$45.57	-85.9%	COM	42225T107
—	LUMIRADX LTD	5,352,106	$73	0.0%	$8.91	—	COM	G5709L117